Tango Therapeutics (TNGX) Equity Ratio (2020 - 2025)
Historic Equity Ratio for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to 0.76.
- Tango Therapeutics' Equity Ratio rose 1711.17% to 0.76 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76, marking a year-over-year increase of 1711.17%. This contributed to the annual value of 0.63 for FY2024, which is 26.5% up from last year.
- According to the latest figures from Q3 2025, Tango Therapeutics' Equity Ratio is 0.76, which was up 1711.17% from 0.57 recorded in Q2 2025.
- In the past 5 years, Tango Therapeutics' Equity Ratio ranged from a high of 0.76 in Q3 2025 and a low of 0.03 during Q1 2021
- Its 5-year average for Equity Ratio is 0.57, with a median of 0.63 in 2024.
- In the last 5 years, Tango Therapeutics' Equity Ratio soared by 222126.86% in 2021 and then crashed by 1715.52% in 2023.
- Quarter analysis of 5 years shows Tango Therapeutics' Equity Ratio stood at 0.69 in 2021, then dropped by 17.08% to 0.57 in 2022, then increased by 10.0% to 0.63 in 2023, then grew by 0.27% to 0.63 in 2024, then rose by 20.81% to 0.76 in 2025.
- Its Equity Ratio stands at 0.76 for Q3 2025, versus 0.57 for Q2 2025 and 0.61 for Q1 2025.